Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.45 USD | +4.80% | -5.88% | -8.97% |
Chart calendar Pharvaris N.V.
Upcoming events on Pharvaris N.V.
Past events on Pharvaris N.V.
2025-01-15 08:15 pm | JP Morgan Healthcare Conference |
2024-12-12 02:45 pm | Oppenheimer Movers in Rare Disease Summit - Panel |
2024-12-04 03:50 pm | Evercore ISI HealthCONx Conference - Fireside Chat |
2024-11-20 03:00 am | ISPOR Europe Conference |
2024-11-13 04:10 pm | Q3 2024 Earnings Release |
2024-11-13 09:30 am | Guggenheim Securities Healthcare Innovation Conference |
2024-11-07 02:30 pm | Canadian Society of Allergy and Clinical Immunology Scientific Meeting - FRCPC, FAAAAI |
2024-11-07 02:30 pm | Canadian Society of Allergy and Clinical Immunology Scientific Meeting - William H. Yang, M.D. |
2024-11-07 02:30 pm | Canadian Society of Allergy and Clinical Immunology Scientific Meeting - Hugo Chapdelaine |
2024-10-25 05:45 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R101) |
2024-10-25 05:30 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R100) |
2024-10-25 04:30 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R112) |
2024-10-25 03:00 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R090) |
2024-10-25 02:30 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R088) |
2024-10-25 02:15 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R103) |
2024-10-25 02:00 pm | American College of Allergy, Asthma & Immunology Meeting - e-Poster (R102) |
2024-10-23 10:00 am | Business Update Call |
2024-10-20 12:30 pm | Japanese Society of Allergology Meeting |
2024-10-05 04:08 am | Global Angioedema Forum - Anna Valerieva |
2024-10-05 03:59 am | Global Angioedema Forum - Marc A. Reidel |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 7,25 |
EBITDA Million EUR | Released Forecast Spread | -45,9 -63,8 28.06% | -75,2 -83,1 9.45% | -86,0 -90,3 4.76% | -133 | -163 | -170 |
EBIT Million EUR | Released Forecast Spread | -54,1 -60,1 9.98% | -86,7 -84,2 -2.96% | -96,9 -92,8 -4.42% | -137 | -164 | -183 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 0,00 - | -75,7 -60,6 -24.82% | -99,8 -93,4 -6.84% | -136 | -163 | -185 |
Net income Million EUR | Released Forecast Spread | -42,7 -54,5 21.6% | -76,3 -61,9 -23.37% | -101 -91,9 -9.78% | -138 | -161 | -172 |
EPS EUR | Released Forecast Spread | -1,40 -2,24 37.41% | -2,27 -1,83 -24.16% | -2,63 -2,30 -14.49% | -2,64 | -2,99 | -2,81 |
Announcement Date | 29/03/22 | 05/04/23 | 10/04/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million EUR | Released Forecast Spread | -24,6 -27,7 11.2% | -40,6 | ||||||||||
EBIT Million EUR | Released Forecast Spread | -21,1 -22,9 8.03% | -22,5 -21,4 -4.98% | -26,2 -23,2 -12.91% | -27,2 -26,2 -3.6% | -28,3 -28,7 1.31% | -34,4 -30,1 -14.04% | -37,9 -34,7 -9.11% | -39,4 | -38,4 | -40,3 | -40,6 | -42,0 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -21,8 -20,9 -4.2% | -23,5 -22,1 -6.32% | -32,0 -25,6 -24.96% | -27,7 -27,5 -0.9% | -29,7 -30,4 2.48% | -41,5 -32,6 -27.21% | -37,4 | -38,4 | -40,3 | -40,6 | -42,0 | |
Net income Million EUR | Released Forecast Spread | -22,6 -23,8 4.91% | -21,9 -20,8 -5.27% | -23,6 -22,0 -7.21% | -32,7 -25,6 -27.88% | -28,0 -27,4 -2.41% | -29,7 -29,9 0.5% | -41,7 -33,5 -24.54% | -38,3 | -38,3 | -39,6 | -39,9 | -40,8 |
EPS EUR | Released Forecast Spread | -0,67 -0,69 2.33% | -0,63 -0,60 -4.83% | -0,58 -0,61 5.29% | -0,76 -0,57 -34.32% | -0,52 -0,55 5.45% | -0,55 -0,56 1.39% | -0,77 -0,62 -24.66% | -0,71 | -0,73 | -0,76 | -0,76 | -0,78 |
Announcement Date | 08/05/23 | 07/08/23 | 02/11/23 | 10/04/24 | 08/05/24 | 14/08/24 | 13/11/24 | - | - | - | - | - |
Past sector events for Pharvaris N.V.
2025-01-10 12:34 am | POLARIS GROUP: December 2024 Sales and Revenue Release |
2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
2024-11-13 | VORONOI, INC.: Q3 2024 Earnings Release |
2024-11-13 | GNI GROUP LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHVS Stock
- Calendar Pharvaris N.V.